EWS::FLI1 is an attractive therapeutic target in Ewing sarcoma tumors because it is required for tumorigenesis, but directly targeting this oncoprotein has been challenging despite significant efforts over the past three decades (82). This evidence concerns the gene FLI1 and Ewing sarcoma.